$0.88-0.04 (-4.03%)
SelectQuote, Inc.
SelectQuote, Inc. in the Financial Services sector is trading at $0.88. The stock is currently near its 52-week low of $0.56, remaining 40.4% below its 200-day moving average. Technical signals show neutral RSI of 69 and bullish MACD crossover, explaining why SLQT maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Servi...
SelectQuote (SLQT) has rebounded 54% over the past month, supported by a Trend Seeker “Buy” signal since April 17. SLQT remains highly speculative, with a 72% loss over the past year. Analysts expect revenue growth of 8.82% this year and 6.11% next, with earnings projected to rebound 625% after a...
Analysts have trimmed SelectQuote price targets by about US$1 to US$2, even as one updated model keeps fair value unchanged at US$3.06. These modest cuts reflect fresh research that revisits discount rate assumptions and long term expectations without discarding the existing thesis. Read on to see how to track these shifting targets and keep up with the evolving SelectQuote story. Stay updated as the Fair Value for SelectQuote shifts by adding it to your watchlist or portfolio. Alternatively,...
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SelectQuote Inc. (NYSE:SLQT) is one of the best penny stocks under $1 to buy right now. On February 5, SelectQuote reported a 12% year-over-year revenue increase to $537 million for FQ2 2026, driven by a strong performance in its senior segment and a 26% revenue jump for SelectRx. To support its expansion, SelectQuote secured a […]
SelectQuote’s updated analyst narrative now centers on a fair value move from $4.50 to about $3.06 per share, a sizable reset in where some models see the stock’s potential. Bulls view this shift as a cleaner, more execution focused starting point, while bears see it as a sign that earlier expectations were too aggressive. As you read on, you will see how to track these evolving views and what to watch if you are following the story. Stay updated as the Fair Value for SelectQuote shifts by...